Related Experiment Video
Updated: Jul 17, 2025

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
Published on: June 22, 2016
Aberrant frequency of TNFR2-expressing CD4+ FoxP3+ regulatory T cells in nasopharyngeal carcinoma patients
Engku Nur Syafirah Engku Abd Rahman1, Ahmad Adebayo Irekeola2, Rafidah Hanim Shueb1
1Department of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 16150 Kubang Kerian, Kelantan, Malaysia.
Abstract:
TNFR2 is a surface marker of highly suppressive subset of CD4+ FoxP3+ regulatory T cells (Tregs) in humans and mice. This study examined the TNFR2 expression by Tregs of nasopharyngeal carcinoma (NPC) patients and healthy controls. The proliferation, migration, survival of TNFR2+ Tregs, and association with clinicopathological characteristics were assessed. The expression levels of selected cytokines were also determined. The results demonstrated that in both peripheral blood (PB) (10.45 ± 5.71%) and tumour microenvironment (TME) (54.38 ± 16.15%) of NPC patients, Tregs expressed TNFR2 at noticeably greater levels than conventional T cells (Tconvs) (3.91 ± 2.62%, p < 0.0001), akin to healthy controls. Expression of TNFR2 (1.06 ± 0.99%) was correlated better than CD25+ (0.40 ± 0.46%) and CD127-/low (1.00 ± 0.83% ) with FoxP3 expression in NPC PB (p = 0.0005). Though there was no significant association between TNFR2 expression with the functional capacity (proliferation, migration and survival) of Tregs (p > 0.05), the proportions of PB and TME TNFR2+ Tregs in NPC patients showed more proliferative, higher migration capacity, and better survival ability, as compared to those in healthy controls. Furthermore, TNFR2+ Tregs from NPC patients expressed significantly higher amounts of IL-6 (p = 0.0077), IL-10 (p = 0.0001), IFN-γ (p = 0.0105) and TNF-α (p < 0.0001) than those from healthy controls. Most significantly, TNFR2 expression in maximally suppressive Tregs population were linked to WHO Type III histological type, distant metastasis, progressive disease status, and poor prognosis for NPC patients. Hence, our research implies that TNFR2 expression by PB and TME Tregs may be a useful predictive indicator in NPC patients.
Insights
Tumor necrosis factor receptor 2 (TNFR2) is elevated on regulatory T cells (Tregs) in nasopharyngeal carcinoma (NPC) patients. TNFR2+ Tregs correlate with advanced disease and poor prognosis, suggesting TNFR2 as a predictive biomarker for NPC.
Area of Science:
- Immunology
- Oncology
Background:
- Regulatory T cells (Tregs) expressing CD4 and FoxP3 are crucial for immune suppression.
- Tumor necrosis factor receptor 2 (TNFR2) is a surface marker on highly suppressive CD4+ FoxP3+ Tregs.
- Nasopharyngeal carcinoma (NPC) is a malignancy where immune cell dynamics play a significant role.
Purpose of the Study:
- To investigate TNFR2 expression on Tregs in NPC patients compared to healthy controls.
- To assess the functional capacity (proliferation, migration, survival) of TNFR2+ Tregs.
- To determine the association between TNFR2+ Tregs and clinicopathological characteristics, including prognosis.
Main Methods:
- Flow cytometry was used to quantify TNFR2 expression on Tregs in peripheral blood (PB) and tumor microenvironment (TME) of NPC patients and healthy controls.
- Functional assays assessed Treg proliferation, migration, and survival.
- Cytokine expression levels (IL-6, IL-10, IFN-γ, TNF-α) were measured.
- Correlation analysis was performed between TNFR2 expression and clinicopathological features.
Main Results:
- NPC patients exhibited significantly higher TNFR2 expression on Tregs in both PB and TME compared to conventional T cells.
- TNFR2 expression correlated better with FoxP3 than CD25 or CD127 in NPC PB.
- While no direct association with Treg function was found, TNFR2+ Tregs from NPC patients demonstrated enhanced proliferation, migration, and survival, along with higher levels of IL-6, IL-10, IFN-γ, and TNF-α compared to controls.
- TNFR2 expression on suppressive Tregs was linked to WHO Type III histology, distant metastasis, progressive disease, and poor prognosis.
Conclusions:
- TNFR2 is significantly upregulated on Tregs in NPC patients.
- TNFR2+ Tregs in NPC exhibit heightened functional capacity and express higher levels of key cytokines.
- TNFR2 expression on Tregs serves as a potential predictive biomarker for disease progression and poor prognosis in NPC.
More Related Videos
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
15:33Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
Published on: August 13, 2013
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...